Basel Medical Group

Basel Medical Group R&D per Employee

R&D Spending per Employee of Basel Medical Group (BMGL) as of Nov 2, 2026.

R&D per Employee

-SGD

Last updated:

R&D Spending per Employee of Basel Medical Group is 2026 - SGD. R&D Spending per Employee of Basel Medical Group was 2025 - SGD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Basel Medical Group Stock analysis

What does Basel Medical Group do? Basel Medical Group Ltd. generates revenue through orthopedic surgeries, medical care, and diagnosis services. The company offers a comprehensive range of orthopedic, trauma, and sports medicine services, including knee and hip replacements, spine surgery, foot and ankle procedures, and minimally invasive treatments. Its services encompass non-surgical options like medications, injections, splinting, and physiotherapy, alongside surgical procedures such as complex surgeries and minimally invasive techniques. The company also provides rehabilitative therapy, including in-house physiotherapy for post-surgery recovery and sports therapy, as well as neurosurgical care for spinal and brain conditions, covering treatments for headaches, brain tumors, spinal issues, aneurysms, and strokes. The primary customers for Basel Medical Group Ltd.'s services are patients requiring orthopedic, trauma, and sports medicine treatments, as well as those needing rehabilitative therapy or neurosurgical care. The company serves individuals seeking specialized medical care for conditions ranging from joint replacements to complex spinal and neurological disorders. Its offerings cater to a broad spectrum of medical needs, from routine orthopedic procedures to advanced neurosurgical interventions, ensuring comprehensive care for diverse patient segments. Basel Medical Group Ltd. operates as an investment holding company focused on healthcare services, with its revenue streams derived from delivering orthopedic surgeries, medical diagnostics, and therapeutic treatments. The company's service portfolio includes both non-surgical and surgical orthopedic care, rehabilitative therapy, and neurosurgical services, all aimed at addressing various medical conditions through specialized treatment options. Its business model relies on providing high-quality, specialized medical services to patients across multiple healthcare segments. Basel Medical Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Basel Medical Group stock

On Eulerpool you can find the complete historical development of R&D Spending per Employee Basel Medical Group since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's SGD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Basel Medical Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Basel Medical Group

All Key Metrics — Basel Medical Group